This is BrainsWay’s global website. The website includes information on clinical indications that were not cleared by the FDA and are considered investigational by the U.S. medical device regulations. BrainsWay D treatment is FDA cleared for patients with MDD who failed to respond to one or more anti-depressants in the current episode.
BrainsWay is ushering in a new era of brain disorder treatment. Through ongoing investment in R&D and in research initiatives ranging from large-scale multicenter trials to personalized medicine studies, BrainsWay represents the next-generation of treatments for depression, OCD, and other brain disorders, achieving outcomes not thought possible with traditional medical solutions.
BrainsWay Introduces the First FDA Cleared (De-Novo) Non-invasive Medical Device for the Treatment of OCD.
Major Depressive Disorder is a neuropsychiatric disorder that is expressed in emotional, physiological and behavioral effects.
OF POPULATION IS COVERED BY REIMBURSEMENT
Regain your confidence and learn more about BrainsWay’s groundbreaking technology.
Read what patients share about their experience
Does BrainsWay’s TMS treatment entail any side effects or risks?
BrainsWay Deep TMS treatment has been proven safe and effective, and
I have a patient who tried several antidepressants and had poor results – what are the chances of improvement using
What are the CE indications for BrainsWay Deep TMS?
BrainsWay has been cleared by the CE for a variety of brain
Typically, patients hear a tapping sound and feel a tapping sensation in the head area during BrainsWay Deep TMS therapy